Company Update – STABLECOIN DEVELOPMENT CORP
STABLECOIN DEVELOPMENT CORP (NYSE: STABLECOIN) is a health‑care pharmaceutical company focused on the topical anti‑infective market. As of the latest trading session on 31 August 2026, the stock closed at $0.8598, with a 52‑week low of $0.8501 and a 52‑week high of $99.75. The company’s market capitalization stands at $25.59 million, and its price‑to‑earnings ratio is 0.19.
Recent Market Activity
- Closing Price: $0.8598 (31 Aug 2026)
- 52‑Week Range: $0.8501 – $99.75
- Market Capitalization: $25.59 million
- P/E Ratio: 0.19
These figures provide a snapshot of the company’s recent valuation and market performance.
Industry Context
STABLECOIN DEVELOPMENT CORP operates in the Pharmaceuticals sector of the broader Health Care industry. Its business model centers on the commercialization of innovative topical anti‑infective solutions aimed at treating bacterial and fungal infections. The company’s focus on niche, high‑efficacy products places it within a specialized segment of the pharmaceutical market.
Relevant News Items
No specific news releases directly concerning STABLECOIN DEVELOPMENT CORP were identified in the provided dataset. The recent coverage focuses on developments in the stablecoin and cryptocurrency space, including new launches by Bitwise, Tether, and Circle, as well as regulatory updates from the G20 and Wyoming. These items do not contain information about STABLECOIN DEVELOPMENT CORP’s corporate actions, financial results, or strategic initiatives.
